Stock 000650 RENHE PHARMACY CO.,LTD
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Renhe Pharmacy Co.,Ltd

Equities

000650

CNE000000NF8

End-of-day quote Shenzhen S.E.
Other stock markets
 23:00:00 27/06/2024 BST 		5-day change 1st Jan Change
5.9 CNY +0.68% Intraday chart for Renhe Pharmacy Co.,Ltd +0.34% -11.01%
05-23 Renhe Pharmacy Gets Nod to Market Oseltamivir Phosphate Capsules MT
04-29 Renhe Pharmacy Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Renhe Pharmacy Co.,Ltd Approves Cash Dividend for 2023
CI
Renhe Pharmacy Gets Nod to Market Oseltamivir Phosphate Capsules
MT
Renhe Pharmacy Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Renhe Pharmacy Co., Ltd. Proposes Final Cash Dividend for the Year 2023
CI
Renhe Pharmacy Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Renhe Pharmacy Gets 58 Million Yuan in Government Grants
MT
Tranche Update on Renhe Pharmacy Co., Ltd.'s Equity Buyback Plan announced on December 8, 2023.
CI
Renhe Pharmacy Co., Ltd.'s Equity Buyback announced on December 8, 2023, has closed with 15,500,000 shares, representing 1.11% for CNY 100.01 million.
CI
Tranche Update on Renhe Pharmacy Co., Ltd.'s Equity Buyback Plan announced on December 8, 2023.
CI
Renhe Pharmacy Co., Ltd. announces an Equity Buyback for CNY 150 million worth of its shares.
CI
Renhe Pharmacy Co., Ltd. authorizes a Buyback Plan.
CI
Renhe Pharmacy Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Renhe Pharmacy Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Renhe Pharmacy Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2022, Payable on 08 June 2023
CI
Renhe Pharmacy Co., Ltd. Approves Cash Dividend for 2022
CI
Renhe Pharmacy Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Renhe Pharmacy Co., Ltd. Proposes Final Cash Dividend for 2022
CI
Renhe Pharmacy Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Renhe Pharmacy Gets Nod Tadalafil Tablets' Registration
MT
Renhe Pharmacy Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 000650 Stock
  4. News Renhe Pharmacy Co.,Ltd
  5. Highlights